Jon Cuthbert

Mount Hope Mining (ASX:MHM) has commenced a gradient array induced polarisation survey across its camp-scale MS2 Gold Corridor in New South Wales.

Medical Developments International (ASX:MVP) announced that CEO Brent MacGregor will step down from his position.

Crypto transfers from Canada to India, China and the Philippines reached US$2.36 billion, up 141% year-on-year, according to Chainalysis’ 2026 Geography of Cryptocurrency Report.

Southern Cross Gold Consolidated (ASX:SX2) welcomed an $20 million election commitment to establish Australia's first antimony processing facility in northern Victoria.

The Blockchain Association (BA) and Crypto Council for Innovation (CCI) have asked an Illinois court to accelerate its review of challenges to the state’s Digital Asset Tax Act.

AMP (ASX:AMP) reported total wealth assets under management of $168 billion for the third quarter of 2026.

Takeda Pharmaceutical (NYSE:TAK) presented new data from the pivotal Phase 2/3 IgGNITE clinical trial (TAK-881-3001) evaluating TAK-881 Immune Globulin Subcutaneous (Human), 20% Solution combined with recombinant human hyaluronidase.

Eton Pharmaceuticals (NASDAQ:ETON) announced exclusive U.S. licensing and supply agreements with Aquestive Therapeutics (NASDAQ:AQST) for LIBERVANT, a seizure-cluster treatment.

Ocugen (NASDAQ:OCGN) entered an agreement granting Roots Pharmaceutical exclusive regional rights to OCU400, an investigational gene therapy for retinitis pigmentosa, an inherited vision-loss disease.

Oil prices moved higher after vessels were struck in the Strait of Hormuz and Iranian officials said new tactics were being used to target ships in the region.